ArticleMagnetic resonance in medicine2025
TE optimization for J-difference editing of 2-hydroxyglutarate at 3T.
Article in Magnetic resonance in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T.Magnetic resonance in medicine · 2026Article
- TE optimization for J-difference editing of 2-hydroxyglutarate at 3T.Magnetic resonance in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeTo investigate the TE dependence of the edited 2-hydroxyglutarate (2HG) signal, its separation from co-edited glutamate plus glutamine (Glx), and fit accuracy in the presence of nuisance signals using a MEGA-PRESS sequence.
methodsSimulations were performed at TEs 70-160 ms to assess the signal intensity and 2HG-Glx overlap as a function of TE. The effect of the 2HG-Glx spectral overlap on the fit accuracy of 2HG was evaluated on simulated 2HG-edited spectra with in vivo parameter variations. Data were acquired at TEs of 70 and 90 ms in 13 glioma patients to estimate the TE-dependence of the 2HG and Glx signal intensity and at a TE of 120 ms in eight glioma patients to estimate the in vivo 2HG, Glx, and water T2 relaxation times.
resultsA TE of 90 ms was found to produce a maximal 2HG integral, which was 23% larger than that at a TE of 70 ms in vivo without a significant increase in 2HG-Glx overlap. Lipid and residual water were 26% and 16% lower, respectively, at a TE of 90 ms versus 70 ms. Fit-quality numbers were 49% lower at a TE of 90 ms versus 70 ms, indicating enhanced fits at a TE of 90 ms. The in vivo T2 relaxation times of 2HG, Glx, and water were 264, 177, and 110 ms, respectively.
conclusionA TE of 90 ms was best with a maximal 2HG signal, minimal 2HG-Glx overlap, and minimal residual water and lipid contamination.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.